Navigation Links
Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
Date:3/30/2009

ConsentSolutions, Inc., a provider of electronic informed consent software for clinical research trials has named Jovianna DiCarlo President & Chief Executive Officer. Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical therapeutics and devices through the entire development process from conceptualization, feasibility assessment, through clinical development to commercialization.

Frederick, MD (PRWEB) March 30, 2009 -- ConsentSolutions, Inc., a provider of electronic informed consent software for clinical research trials has named Jovianna DiCarlo President & Chief Executive Officer. Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical therapeutics and devices through the entire development process from conceptualization, feasibility assessment, through clinical development to commercialization.

Ms. DiCarlo most recently served as the Dermatology Clinical Development Manager for NitricBio Therapeutics, Inc., an early stage biotechnology company where she led dermatology product development, and topical infectious disease drug/device development, and clinical trial programs all of which she managed through the identification and implementation of a customized platform of electronic clinical trial management applications.

Additionally, Ms. DiCarlo has utilized her extensive operational technology & regulatory expertise to combine intelligent electronic technology systems integration to develop and map operational and workflow processes to successfully support the launch several full service eCRO's, eIRB's, eSMO's, eResearch consortiums, and dedicated clinical research sites.

"I am passionate about actively contributing clinical research and development initiatives through the development, integration, adoption and implementation of intelligent technology applications to efficiently support clinical operations, and clinical research & development initiatives," said DiCarlo.

"My experience in deploying efficient real-time electronic applications to manage clinical trials leads me to believe that both industry and regulatory authorities will embrace the adoption and use of electronic clinical trial informed consenting practices."

We are pleased that Ms DiCarlo has joined us, says Susan Brink, DrPH, Chairman of the Board. Her track successful track record of applying technology solutions to support clinical trials, along with her business development acumen, EDC/CTMS, IRB, subject recruitment organizations, and CRO industry contacts position her to well to form technology business to business partnerships that will create added value for ConsentSolutions, Inc.

About ConsentSolutions, Inc
Founded in 2005, headquartered in Frederick, Maryland, with offices in Gaithersburg, ConsentSolutions is focused on adding value to the consenting process through the development of interactive, user-friendly educational software to effectively deliver clinical trial information electronically allowing study candidates to make important decisions about clinical trial participation. With decades of combined experience developing educational multimedia applications, ConsentSolutions, Inc. senior management team is dedicated to the goal of shared decision making for trial participation among study candidates, clinical trial coordinators, investigators, and physicians.

For more information contact:

Jovianna DiCarlo, President & CEO
jdicarlo (at) consentsolutions (dot) com
240-575-1918 Ext. 261
267.884.3456
www.consentsolutions.com

# # #

Read the full story at http://www.prweb.com/releases/2009/03/prweb2270884.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
2. US Oncology Named to FORTUNE Magazines Most Admired Companies List for Third Time
3. Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
4. Zymetis Inc. Named Top 50 Cleantech/Greentech Company
5. BioNanomatrixs Revolutionary Whole Genome Analysis Platform Named to MIT Technology Reviews Annual 10 Emerging Technologies List
6. Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
7. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
8. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
9. Kendle Named a Best Place to Work in Greater Cincinnati
10. Sinovac Named to Deloitte Technology Fast 50 China
11. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
Breaking Biology News(10 mins):